FDA warns of counterfeit ozempic

The U.S. Meals and Drug Administration has uncovered unsuitable Ozempic shots in the legitimate U.S. drug provide chain, and is warning patients to be on their guard.
The FDA said Thursday that it has seized thousands of unsuitable doses of Ozempic, the weight-loss drug manufactured by Novo Nordisk, nonetheless warned that extra would possibly per chance per chance well collected be accessible for occupy.
Sufferers, practitioners and pharmacies are particularly warned now not to sell or exercise Ozempic 1-milligram (mg) injections labeled with lot amount NAR0074 and serial amount 430834149057, the FDA said.
Individuals in possession of Ozempic doses meeting that description can file the unsuitable product in the present day to the FDA’s Office of Felony Investigations, the company said.
The company and the drugmaker are making an strive out the seized merchandise, nonetheless assemble now not respect any files but about the fraudulent medicines’ identification, quality or security.
5 americans respect gotten ill from injections of the unsuitable Ozempic, nonetheless no circumstances had been excessive, the FDA said.
The sickened patients all suffered unintended effects in step with legitimate Ozempic, fancy nausea, vomiting, diarrhea, abdominal distress and constipation.
The the rest of the Ozempic injection kit is moreover unsuitable, in conjunction with the needles, the injection pen impress, the carton and the accompanying doctor and patient files, the FDA said.
On yarn of the needles are unsuitable, their sterility can now not be guaranteed and an injection gifts an infection risk to any individual the utilization of the fraudulent product, the FDA said.
In a news launch issued Thursday, Novo Nordisk encouraged patients to easiest aquire Ozempic through pharmacies.
“If a prescription is filled by process of a major retailer who makes exercise of our licensed distributors, Novo Nordisk believes the risk of receiving unsuitable product is minimized,” the firm said.
The FDA seizures took set up in warehouses birth air the firm’s licensed provide chain, Novo Nordisk informed NBC Facts.
Copyright © 2023 HealthDay. All rights reserved.
Quotation:
FDA warns of unsuitable ozempic (2023, December 22)
retrieved 23 December 2023
from https://medicalxpress.com/news/2023-12-fda-unsuitable-ozempic.html
This file is field to copyright. Other than any ideal dealing for the reason of non-public gaze or research, no
phase would possibly per chance per chance well be reproduced with out the written permission. The issue material is supplied for files choices easiest.







